F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 36.55 SEK -4.82% Market Closed
Market Cap: 497.8m SEK
Have any thoughts about
Fluoguide AS?
Write Note

P/FCFE
Price to FCFE

-8.4
Current
-19.3
Median
27.3
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-8.4
=
Market Cap
453.6m SEK
/
FCFE
-34.6m DKK
All Countries
Close
Market Cap P/FCFE
DK
Fluoguide AS
STO:FLUO
453.6m SEK -8.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 136 942.1
US
Abbvie Inc
NYSE:ABBV
352.5B USD 14.1
US
Amgen Inc
NASDAQ:AMGN
174.8B USD 29.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD -95.2
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD 12
US
Epizyme Inc
F:EPE
94.1B EUR -437.4
AU
CSL Ltd
ASX:CSL
137.9B AUD 82.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD 27.5
US
Seagen Inc
F:SGT
39.3B EUR -60.1
NL
argenx SE
XBRU:ARGX
33.2B EUR -107.5
 
DK
F
Fluoguide AS
STO:FLUO
Average P/FCFE: 33.1
Negative Multiple: -8.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 136 942.1
US
Abbvie Inc
NYSE:ABBV
14.1
US
Amgen Inc
NASDAQ:AMGN
29.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -95.2
US
Gilead Sciences Inc
NASDAQ:GILD
12
US
E
Epizyme Inc
F:EPE
Negative Multiple: -437.4
AU
CSL Ltd
ASX:CSL
82.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
27.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -107.5

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More